Clinical trial Recruiting at 1 site Observational Ages 18 to 55 Women only

An anatomical system to guide surgery for placenta accreta

Official title: Evaluation of Clinical Outcomes and Acceptability of an Anatomical Classification for Placenta Accreta

Run by University of California, Los Angeles · NCT07283042 · Data updated 2026-11-12

This project will try using an intraoperative anatomical classification to help surgeons choose the safest operation for pregnant people at risk of placenta accreta.

Quick facts

Study typeObservational
Ages18 Years to 55 Years
SexWomen only
Enrollment60 (estimated)
SponsorUniversity of California, Los Angeles
Academic / other
Locations1 site (Los Angeles, California)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedJanuary 16, 2026
Trial IDNCT07283042 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant people aged 18–55 with prenatal ultrasound or clinical risk factors for placenta accreta who plan surgical management and can provide informed consent are ideal candidates.

Probably not a fit

People without prenatal PAS risk factors, those managed nonoperatively, or those who cannot undergo planned surgery at the study site are unlikely to benefit from this intraoperative classification.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective cohort study that integrates prenatal ultrasound staging with a structured intraoperative topographic classification to guide surgical decision-making for placenta accreta spectrum. Patients undergo standardized prenatal assessment, real-time intraoperative staging with photos and videos, and then surgical management chosen according to the classification (from cesarean hysterectomy to one-step conservative procedures). The study will collect intraoperative blood loss metrics, correlate surgical findings with pathology, and compare preoperative ultrasound to intraoperative and postoperative data to validate the system. Data collection and follow-up are planned over approximately 36–48 months to assess feasibility, acceptability, and clinical outcomes.

Why it matters

Potential benefit: If successful, the classification could help surgeons pick procedures that reduce blood loss and complications and improve surgical outcomes for people with placenta accreta.

How similar studies have gone: Related ultrasound-based staging systems have been described, but real-time intraoperative topographic classification and its formal validation in surgical decision-making remain relatively novel with limited prior evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant people suspected of having PAS based on ultrasound findings or clinical risk factors
* Patients undergoing planned surgical intervention for PAS, including a planned cesarean
* Individuals who provide informed consent to participate in the study
* Patients with at least one prenatal assessment before surgery
* Expected age range: 18-55
* Patient has agreed to conservative management approach as part of standard of care if feasible intraoperatively

Exclusion Criteria:

* Patients who decline participation or withdraw consent
* Those with contraindications to the planned surgical procedure

Where it's running

  • University of California, Los Angeles
    Los Angeles, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.